Report date: Jan 21,2025
Conflict count: 358585
Publisher: Bentham Science
Title count: 75
Conflict count: 336


==========================================================

Created: 2015-11-26 06:36:10
ConfID: 5070607
CauseID: 1387545774
OtherID: 1354687917
JT: Current Pharmaceutical Biotechnology
MD: Depukat,13,13,2440,2012,Regeneration of Vessel Wall Functionality and Vascular Restoration Therapy with Biodegradable Stents - Current Status
DOI: 10.2174/138920112804583014(Journal) (5070607-N)
DOI: 10.2174/1389201011208062440(Journal)
==========================================================

Created: 2015-11-26 06:36:10
ConfID: 5070606
CauseID: 1387545774
OtherID: 1354687917
JT: Current Pharmaceutical Biotechnology
MD: Jawien,13,13,2435,2012,The Role of An Experimental Model of Atherosclerosis: apoE-knockout Mice in Developing New Drugs against Atherogenesis
DOI: 10.2174/138920112804583023(Journal) (5070606-N)
DOI: 10.2174/1389201011208062435(Journal)
==========================================================

Created: 2015-11-26 06:36:10
ConfID: 5070617
CauseID: 1387545774
OtherID: 1354687917
JT: Current Pharmaceutical Biotechnology
MD: Czuriga,13,13,2532,2012,Cellular Mechanisms for Diastolic Dysfunction in the Human Heart
DOI: 10.2174/138920112804583005(Journal) (5070617-N)
DOI: 10.2174/1389201011208062532(Journal)
==========================================================

Created: 2015-11-26 06:36:10
ConfID: 5070616
CauseID: 1387545774
OtherID: 1354687917
JT: Current Pharmaceutical Biotechnology
MD: Hamdani,13,13,2522,2012,Alteration of the Beta-Adrenergic Signaling Pathway in Human Heart Failure
DOI: 10.2174/138920112804582998(Journal) (5070616-N)
DOI: 10.2174/1389201011208062522(Journal)
==========================================================

Created: 2015-11-26 06:36:10
ConfID: 5070618
CauseID: 1387545774
OtherID: 1354687917
JT: Current Pharmaceutical Biotechnology
MD: Kasner,13,13,2539,2012,Diastolic Heart Failure and LV Dyssynchrony
DOI: 10.2174/138920112804582989(Journal) (5070618-N)
DOI: 10.2174/1389201011208062539(Journal)
==========================================================

Created: 2015-11-26 06:36:10
ConfID: 5070613
CauseID: 1387545774
OtherID: 1354687917
JT: Current Pharmaceutical Biotechnology
MD: Petkow Dimitrow,13,13,2497,2012,Pharmacotherapy of Aortic Stenosis-Success or Failure?
DOI: 10.2174/138920112804583096(Journal) (5070613-N)
DOI: 10.2174/1389201011208062497(Journal)
==========================================================

Created: 2015-11-26 06:36:10
ConfID: 5070612
CauseID: 1387545774
OtherID: 1354687917
JT: Current Pharmaceutical Biotechnology
MD: Falcao-Pires,13,13,2485,2012,Understanding the Molecular and Cellular Changes Behind Aortic Valve Stenosis
DOI: 10.2174/138920112804583050(Journal) (5070612-N)
DOI: 10.2174/1389201011208062485(Journal)
==========================================================

Created: 2015-11-26 06:36:10
ConfID: 5070615
CauseID: 1387545774
OtherID: 1354687917
JT: Current Pharmaceutical Biotechnology
MD: Papp,13,13,2515,2012,How Cardiomyocytes Make the Heart Old
DOI: 10.2174/138920112804583104(Journal) (5070615-N)
DOI: 10.2174/1389201011208062515(Journal)
==========================================================

Created: 2015-11-26 06:36:10
ConfID: 5070614
CauseID: 1387545774
OtherID: 1354687917
JT: Current Pharmaceutical Biotechnology
MD: Gavina,13,13,2503,2012,Left Ventricular Hypertrophy in Isolated Aortic Stenosis: Primetime for the Ventricle
DOI: 10.2174/138920112804583032(Journal) (5070614-N)
DOI: 10.2174/1389201011208062503(Journal)
==========================================================

Created: 2015-11-26 06:36:10
ConfID: 5070608
CauseID: 1387545774
OtherID: 1354687917
JT: Current Pharmaceutical Biotechnology
MD: Jankowski,13,13,2449,2012,How Drugs Influencing Central Blood Pressure Prevent Atherosclerosis Complications?
DOI: 10.2174/138920112804583078(Journal) (5070608-N)
DOI: 10.2174/1389201011208062449(Journal)
==========================================================

Created: 2015-11-26 06:36:10
ConfID: 5070611
CauseID: 1387545774
OtherID: 1354687917
JT: Current Pharmaceutical Biotechnology
MD: Bela Kertesz,13,13,2477,2012,Fabry Disease Cardiomyopathy: from Genes to Clinical Manifestations
DOI: 10.2174/138920112804583069(Journal) (5070611-N)
DOI: 10.2174/1389201011208062477(Journal)
==========================================================

Created: 2015-11-26 06:36:10
ConfID: 5070610
CauseID: 1387545774
OtherID: 1354687917
JT: Current Pharmaceutical Biotechnology
MD: W. Friedrich,13,13,2467,2012,Genetics of Hypertrophic and Dilated Cardiomyopathy
DOI: 10.2174/138920112804583041(Journal) (5070610-N)
DOI: 10.2174/1389201011208062467(Journal)